228 related articles for article (PubMed ID: 22892101)
1. Activity of tribendimidine and praziquantel combination therapy against the liver fluke Opisthorchis viverrini in vitro and in vivo.
Keiser J; Adelfio R; Vargas M; Odermatt P; Tesana S
J Helminthol; 2013 Jun; 87(2):252-6. PubMed ID: 22892101
[TBL] [Abstract][Full Text] [Related]
2. A study of tribendimidine effects in vitro and in vivo on the liver fluke Opisthorchis felineus.
Pakharukova MY; Samsonov VA; Serbina EA; Mordvinov VA
Parasit Vectors; 2019 Jan; 12(1):23. PubMed ID: 30635027
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial.
Soukhathammavong P; Odermatt P; Sayasone S; Vonghachack Y; Vounatsou P; Hatz C; Akkhavong K; Keiser J
Lancet Infect Dis; 2011 Feb; 11(2):110-8. PubMed ID: 21111681
[TBL] [Abstract][Full Text] [Related]
4. Opisthorchis viverrini: efficacy and tegumental alterations following administration of tribendimidine in vivo and in vitro.
Keiser J; Utzinger J; Xiao SH; Odermatt P; Tesana S
Parasitol Res; 2008 Mar; 102(4):771-6. PubMed ID: 18172689
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial.
Sayasone S; Keiser J; Meister I; Vonghachack Y; Xayavong S; Senggnam K; Phongluxa K; Hattendorf J; Odermatt P
Lancet Infect Dis; 2018 Feb; 18(2):155-161. PubMed ID: 29153938
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of tribendimidine against Opisthorchis viverrini: two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials.
Sayasone S; Odermatt P; Vonghachack Y; Xayavong S; Senggnam K; Duthaler U; Akkhavong K; Hattendorf J; Keiser J
Lancet Infect Dis; 2016 Oct; 16(10):1145-1153. PubMed ID: 27472949
[TBL] [Abstract][Full Text] [Related]
7. The first comprehensive study of praziquantel effects in vivo and in vitro on European liver fluke Opisthorchis felineus (Trematoda).
Pakharukova MY; Shilov AG; Pirozhkova DS; Katokhin AV; Mordvinov VA
Int J Antimicrob Agents; 2015 Jul; 46(1):94-100. PubMed ID: 25862308
[TBL] [Abstract][Full Text] [Related]
8. Effects of miconazole/clotrimazole and praziquantel combinations against the liver fluke Opisthorchis felineus in vivo and in vitro.
Pakharukova MY; Pakharukov YV; Mordvinov VA
Parasitol Res; 2018 Jul; 117(7):2327-2331. PubMed ID: 29721656
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum.
Tritten L; Nwosu U; Vargas M; Keiser J
Acta Trop; 2012 Apr; 122(1):101-7. PubMed ID: 22210439
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini.
Keiser J; Shu-Hua X; Chollet J; Tanner M; Utzinger J
Antimicrob Agents Chemother; 2007 Mar; 51(3):1096-8. PubMed ID: 17194822
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of drugs against clonorchiasis and opisthorchiasis: a systematic review and network meta-analysis.
Qian MB; Patel C; Palmeirim MS; Wang X; Schindler C; Utzinger J; Zhou XN; Keiser J
Lancet Microbe; 2022 Aug; 3(8):e616-e624. PubMed ID: 35697047
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of selected anthelmintic compounds for activity against Opisthorchis viverrini.
Tawatsin A; Sirisinha S; Vajrasthira S; Bunnag D; Harinasuta T
Tropenmed Parasitol; 1984 Jun; 35(2):85-90. PubMed ID: 6464190
[TBL] [Abstract][Full Text] [Related]
13. Pooled Population Pharmacokinetic Analysis of Tribendimidine for the Treatment of
Meister I; Assawasuwannakit P; Vanobberghen F; Penny MA; Odermatt P; Sayasone S; Huwyler J; Tarning J; Keiser J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718244
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Praziquantel Against Light Infections of Opisthorchis viverrini: A Randomized Parallel Single-Blind Dose-Ranging Trial.
Sayasone S; Meister I; Andrews JR; Odermatt P; Vonghachack Y; Xayavong S; Senggnam K; Phongluxa K; Hattendorf J; Bogoch II; Keiser J
Clin Infect Dis; 2017 Feb; 64(4):451-458. PubMed ID: 28174906
[TBL] [Abstract][Full Text] [Related]
15. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter.
Deenonpoe R; Chomvarin C; Pairojkul C; Chamgramol Y; Loukas A; Brindley PJ; Sripa B
Asian Pac J Cancer Prev; 2015; 16(5):1751-8. PubMed ID: 25773821
[TBL] [Abstract][Full Text] [Related]
16. Decreased risk of cholangiocarcinogenesis following repeated cycles of Opisthorchis viverrini infection-praziquantel treatment: Magnetic Resonance Imaging (MRI) and histopathological study in a hamster model.
Hanpanich P; Laha T; Sripa B; Mairiang E; Sereerak P; Upontain S; Tangkawattana P; Brindley PJ; Tangkawattana S
Parasitol Int; 2017 Aug; 66(4):464-470. PubMed ID: 27143606
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of tribendimidine, artesunate and praziquantel administered to hamsters infected with Clonorchis sinensis].
Xue J; Xu LL; Qiang HQ; Zhang YN; Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Jun; 27(3):215-8. PubMed ID: 19852361
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the surface tegument of Opisthorchis viverrini exposed to praziquantel in vitro and in vivo.
Sirisinha S; Puengtomwatanakul S; Sobhon P; Saitongdee P; Wongpayabal P; Mitranonde V; Radomyos P; Bunnag D; Harinasuta T
Southeast Asian J Trop Med Public Health; 1984 Mar; 15(1):95-103. PubMed ID: 6740385
[TBL] [Abstract][Full Text] [Related]
19. Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection.
Pinlaor S; Prakobwong S; Boonmars T; Wongkham C; Pinlaor P; Hiraku Y
Acta Trop; 2009 Aug; 111(2):181-91. PubMed ID: 19427296
[TBL] [Abstract][Full Text] [Related]
20. Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro.
Keiser J; Odermatt P; Tesana S
Parasitol Res; 2009 Jul; 105(1):261-6. PubMed ID: 19308455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
